Correlation Between Procaps Group and Pacira BioSciences,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Procaps Group and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procaps Group and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procaps Group SA and Pacira BioSciences,, you can compare the effects of market volatilities on Procaps Group and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procaps Group with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procaps Group and Pacira BioSciences,.

Diversification Opportunities for Procaps Group and Pacira BioSciences,

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Procaps and Pacira is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Procaps Group SA and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Procaps Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procaps Group SA are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Procaps Group i.e., Procaps Group and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Procaps Group and Pacira BioSciences,

Given the investment horizon of 90 days Procaps Group SA is expected to under-perform the Pacira BioSciences,. In addition to that, Procaps Group is 1.93 times more volatile than Pacira BioSciences,. It trades about -0.03 of its total potential returns per unit of risk. Pacira BioSciences, is currently generating about -0.05 per unit of volatility. If you would invest  3,005  in Pacira BioSciences, on August 24, 2024 and sell it today you would lose (1,267) from holding Pacira BioSciences, or give up 42.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Procaps Group SA  vs.  Pacira BioSciences,

 Performance 
       Timeline  
Procaps Group SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Procaps Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Pacira BioSciences, 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Procaps Group and Pacira BioSciences, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Procaps Group and Pacira BioSciences,

The main advantage of trading using opposite Procaps Group and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procaps Group position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.
The idea behind Procaps Group SA and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges